Immunohistological intensity measurements as a tool to assess sarcolemma-associated protein expression

Neuropathology and Applied Neurobiology

Volumn 36, Issue 4, 2010, Pages 265-274

  Arechavala Gomeza, V ^a   Kinali, M ^a   Feng, L ^a   Brown, S C ^b   Sewry, C ^c   Morgan, J E ^a   Muntoni, F ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c ROBERT JONES AND AGNES HUNT ORTHOPAEDIC HOSPITAL   (United Kingdom)

Author keywords

Becker muscular dystrophy; Duchenne muscular dystrophy; Genetic therapies; Immunohistochemistry; Protein quantification

Indexed keywords

DYSTROPHIN; MEMBRANE PROTEIN; SLMAP PROTEIN, HUMAN;

ARTICLE; BECKER MUSCULAR DYSTROPHY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DUCHENNE MUSCULAR DYSTROPHY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOHISTOLOGY; MALE; MUSCLE BIOPSY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; SCHOOL CHILD; VALIDATION PROCESS; CASE CONTROL STUDY; COMPUTER PROGRAM; DIFFERENTIAL DIAGNOSIS; EVALUATION STUDY; FEMALE; GENETICS; HETEROZYGOTE; IMAGE PROCESSING; METABOLISM; MUSCULAR DYSTROPHY, DUCHENNE; PROCEDURES; SARCOLEMMA; SCOLIOSIS; SKELETAL MUSCLE; VALIDATION STUDY;

CASE-CONTROL STUDIES; CHILD; DIAGNOSIS, DIFFERENTIAL; DYSTROPHIN; FEMALE; HETEROZYGOTE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; MALE; MEMBRANE PROTEINS; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, DUCHENNE; SARCOLEMMA; SCOLIOSIS; SOFTWARE;

EID: 77952372081     PISSN: 03051846     EISSN: 13652990     Source Type: Journal    
DOI: 10.1111/j.1365-2990.2009.01056.x     Document Type: Article

References (28)

1. Dubowitz V, Sewry C. Muscle Biopsy: A Practical Approach 3rd edn. SAUNDERS Elsevier, 2007. ISBN: 1-4160-2593-1
2. Karpati G, Carpenter S, Morris GE, Davies KE, Guerin C, Holland P. Localization and quantitation of the chromosome 6-encoded dystrophin-related protein in normal and pathological human muscle. J Neuropathol Exp Neurol 1993 52 : 119 128
3. Jones KJ, Kim SS, North KN. Abnormalities of dystrophin, the sarcoglycans, and laminin alpha2 in the muscular dystrophies. J Med Genet 1998 35 : 379 386
4. Vainzof M, Passos-Bueno MR, Canovas M, Moreira ES, Pavanello RC, Marie SK, Anderson LV, Bonnemann CG, McNally EM, Nigro V, Kunkel LM, Zatz M. The sarcoglycan complex in the six autosomal recessive limb-girdle muscular dystrophies. Hum Mol Genet 1996 5 : 1963 1969
5. Brenman JE, Chao DS, Xia H, Aldape K, Bredt DS. Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy. Cell 1995 82 : 743 752
6. Torelli S, Brown SC, Jimenez-Mallebrera C, Feng L, Muntoni F, Sewry CA. Absence of neuronal nitric oxide synthase (nNOS) as a pathological marker for the diagnosis of Becker muscular dystrophy with rod domain deletions. Neuropathol Appl Neurobiol 2004 30 : 540 545
7. Michele DE, Barresi R, Kanagawa M, Saito F, Cohn RD, Satz JS, Dollar J, Nishino I, Kelley RI, Somer H, Straub V, Mathews KD, Moore SA, Campbell KP. Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies. Nature 2002 418 : 417 422
8. Brockington M, Blake DJ, Prandini P, Brown SC, Torelli S, Benson MA, Ponting CP, Estournet B, Romero NB, Mercuri E, Voit T, Sewry CA, Guicheney P, Muntoni F. Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin alpha2 deficiency and abnormal glycosylation of alpha-dystroglycan. Am J Hum Genet 2001 69 : 1198 1209
9. Sewry CA, Philpot J, Mahony D, Wilson LA, Muntoni F, Dubowitz V. Expression of laminin subunits in congenital muscular dystrophy. Neuromuscul Disord 1995 5 : 307 316
10. Muntoni F. Is a muscle biopsy in Duchenne dystrophy really necessary? Neurology 2001 57 : 574 575
11. Nicholson LV, Davison K, Falkous G, Harwood C, O'Donnell E, Slater CR, Harris JB. Dystrophin in skeletal muscle. I. Western blot analysis using a monoclonal antibody. J Neurol Sci 1989 94 : 125 136
12. Hoffman EP, Brown RH Jr., Kunkel LM. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 1987 51 : 919 928
13. Ishikawa H, Sugie K, Murayama K, Awaya A, Suzuki Y, Noguchi S, Hayashi YK, Nonaka I, Nishino I. Ullrich disease due to deficiency of collagen VI in the sarcolemma. Neurology 2004 62 : 620 623
14. Muntoni F, Torelli S, Ferlini A. Dystrophin and mutations: one gene, several proteins, multiple phenotypes. Lancet Neurol 2003 2 : 731 740
15. Koenig M, Beggs AH, Moyer M, Scherpf S, Heindrich K, Bettecken T, Meng G, Muller CR, Lindlof M, Kaariainen H et al. The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion. Am J Hum Genet 1989 45 : 498 506
16. Monaco AP, Bertelson CJ, Liechti-Gallati S, Moser H, Kunkel LM. An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus. Genomics 1988 2 : 90 5
17. Hoffman EP, Arahata K, Minetti C, Bonilla E, Rowland LP. Dystrophinopathy in isolated cases of myopathy in females. Neurology 1992 42 : 967 975
18. Bonilla E, Schmidt B, Samitt CE, Miranda AF, Hays AP, de Oliveira AB, Chang HW, Servidei S, Ricci E, Younger DS et al. Normal and dystrophin-deficient muscle fibers in carriers of the gene for Duchenne muscular dystrophy. Am J Pathol 1988 133 : 440 445
19. Sherratt TG, Vulliamy T, Strong PN. Evolutionary conservation of the dystrophin central rod domain. Biochem J 1992 287 : 755 759
20. Anderson LV, Davison K. Multiplex western blotting system for the analysis of muscular dystrophy proteins. Am J Pathol 1999 154 : 1017 1022
21. Hoffman EP, Fischbeck KH, Brown RH, Johnson M, Medori R, Loike JD, Harris JB, Waterston R, Brooke M, Specht L et al. Characterization of dystrophin in muscle-biopsy specimens from patients with Duchenne's or Becker's muscular dystrophy. N Engl J Med 1988 318 : 1363 1368
22. Hoffman EP, Morgan JE, Watkins SC, Partridge TA. Somatic reversion/suppression of the mouse mdx phenotype in vivo. J Neurol Sci 1990 99 : 9 25
23. Nicholson LV, Davison K, Johnson MA, Slater CR, Young C, Bhattacharya S, Gardner-Medwin D, Harris JB. Dystrophin in skeletal muscle. II. Immunoreactivity in patients with Xp21 muscular dystrophy. J Neurol Sci 1989 94 : 137 146
24. Bonilla E, Samitt CE, Miranda AF, Hays AP, Salviati G, DiMauro S, Kunkel LM, Hoffman EP, Rowland LP. Duchenne muscular dystrophy: deficiency of dystrophin at the muscle cell surface. Cell 1988 54 : 447 452
25. Kobayashi T, Ohno S, Park-Matsumoto YC, Kameda N, Baba T. Developmental studies of dystrophin and other cytoskeletal proteins in cultured muscle cells. Microsc Res Tech 1995 30 : 437 457
26. Sewry CA. Immunocytochemical analysis of human muscular dystrophy. Microsc Res Tech 2000 48 : 142 154
27. van Deutekom JC, Janson AA, Ginjaar IB, Frankhuizen WS, Aartsma-Rus A, Bremmer-Bout M, den Dunnen JT, Koop K, van der Kooi AJ, Goemans NM, de Kimpe SJ, Ekhart PF, Venneker EH, Platenburg GJ, Verschuuren JJ, van Ommen GJ. Local dystrophin restoration with antisense oligonucleotide PRO051. N Engl J Med 2007 357 : 2677 2686
28. Kinali M, Arechavala-Gomeza V, Feng L, Cirak S, Hunt D, Adkin C, Guglieri M, Ashton E, Abbs S, Nihoyannopoulos P, Garralda ME, Rutherford M, McCulley C, Popplewell L, Graham IR, Dickson G, Wood MJ, Wells DJ, Wilton SD, Kole R, Straub V, Bushby K, Sewry C, Morgan JE, Muntoni F. Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study. Lancet Neurol 2009 : 8 : 918 928